S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Laser breakthrough could send stock soaring 2,467% (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Stop buying AI stocks! (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Laser breakthrough could send stock soaring 2,467% (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Stop buying AI stocks! (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Laser breakthrough could send stock soaring 2,467% (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Stop buying AI stocks! (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Laser breakthrough could send stock soaring 2,467% (Ad)
Applied Materials stock is Ray Dalio's favorite in this new cycle
Palo Alto Networks aims at cyber security leadership
Laser breakthrough could send stock soaring 2,467% (Ad)
Spotify sounding better to analysts as company tunes into profits
3 Reasons the Capital One-Discover merger is a big deal
Stop buying AI stocks! (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
NASDAQ:BIB

ProShares Ultra Nasdaq Biotechnology (BIB) Price, Holdings, & News

$57.15
+0.34 (+0.60%)
(As of 02/21/2024 ET)
Today's Range
$56.35
$57.15
50-Day Range
$51.05
$61.28
52-Week Range
$40.10
$61.37
Volume
6,689 shs
Average Volume
39,797 shs
Market Capitalization
$91.44 million
Assets Under Management
$95.14 million
Dividend Yield
0.05%
Net Expense Ratio
0.95%
BIB stock logo

About ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

BIB Stock Price History

BIB ETF News Headlines

Clear Buy, Sell, or Hold Recommendation on any Stock, FREE
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
BIB ETF Stock Price History
BIB - ProShares Ultra Nasdaq Biotechnology
Clear Buy, Sell, or Hold Recommendation on any Stock, FREE
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
See More Headlines
Receive BIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ProShares
Fund Name
ProShares Ultra Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BIB
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotech Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
329

Fund Statistics

Assets Under Management
$95.14 million
Average Daily Volume
$35,076.00
Discount/Premium
0.01%
Leveraged
2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
45
Put Options
37
Call Options
8
Short Interest
17,900 shs

Miscellaneous

Beta
1.63
Creation Unit
50,000
Creation Fee
$250.00
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

ProShares Ultra Nasdaq Biotechnology Expenses

TypeBIBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.57%0.54%0.47%0.51%
Other Expenses0.33%0.40%0.54%0.33%0.58%
Total Expense1.08%0.72%0.70%0.57%0.70%
Fee Waiver-0.13%-0.53%-0.55%-0.20%-0.57%
Net Expense0.95%0.61%0.60%0.53%0.58%

ProShares Ultra Nasdaq Biotechnology (BIB) Holdings & Exposure

Top 10 BIB Holdings

BIB Sector Exposure

BIB Industry Exposure















BIB ETF - Frequently Asked Questions

How have BIB shares performed in 2024?

ProShares Ultra Nasdaq Biotechnology's stock was trading at $57.05 at the beginning of 2024. Since then, BIB shares have increased by 0.2% and is now trading at $57.15.
View the best growth stocks for 2024 here
.

How often does ProShares Ultra Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology announced a quarterly dividend on Tuesday, December 19th. Shareholders of record on Thursday, December 21st will be paid a dividend of $0.038 per share on Thursday, December 28th. This represents a $0.15 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date of this dividend is Wednesday, December 20th. This is an increase from the stock's previous quarterly dividend of $0.02.
Read our dividend analysis for BIB
.

What does BIB invest in?

ProShares Ultra Nasdaq Biotechnology is a equity fund issued by ProShares. BIB focuses on health care investments and follows the Nasdaq Biotech Index. The fund's investments total to approximately $95.14 million assets under management.

What stocks does ProShares Ultra Nasdaq Biotechnology hold?
What is the management fee for ProShares Ultra Nasdaq Biotechnology?

ProShares Ultra Nasdaq Biotechnology's management fee is 0.75% and has other expenses of 0.33%. However, BIB has a fee waiver of -0.13% to reimburse the expenses. The net expense ratio for BIB is 0.95%.

What other stocks do shareholders of ProShares Ultra Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares Ultra Nasdaq Biotechnology investors own include Walt Disney (DIS), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), Starbucks (SBUX), Advanced Micro Devices (amd), Alibaba Group (BABA), Pfizer (PFE), Intel (INTC) and Visa (V).

Who are ProShares Ultra Nasdaq Biotechnology's major shareholders?

ProShares Ultra Nasdaq Biotechnology's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include IMC Chicago LLC (2.67%), Capital Investment Advisors LLC (0.69%), Toth Financial Advisory Corp (0.70%), Cassaday & Co Wealth Management LLC (0.28%), Cassaday & Co Wealth Management LLC (0.28%) and Palumbo Wealth Management LLC (0.25%).

How do I buy shares of ProShares Ultra Nasdaq Biotechnology?

Shares of BIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BIB) was last updated on 2/22/2024 by MarketBeat.com Staff